Polycystic Ovary Syndrome Clinical Trial
Official title:
StructUred eduCation Programme to Improve Cardiovascular Risk in womEn With polycyStic Ovary Syndrome; SUCCESS Study
Polycystic Ovary syndrome (PCOS) is a common hormonal imbalance affecting about 12% of women
in the UK. The number of women with PCOS is rising. They suffer from a combination of
symptoms including excess hair, irregular/absent periods, and infertility. About 70% of women
with PCOS are obese or overweight, 10% develop type 2 diabetes (T2DM), and 30-40% have some
degrees of abnormality in controlling (metabolising) blood sugar. Studies have shown that if
women with PCOS make change to their lifestyle (diet and activity), they may reduce their
risk of getting diabetes and heart disease in the future. This study aims to develop and test
a programme that can be run in groups (structured education), to support women with PCOS make
the lifestyle changes needed to improve their PCOS and prevent future associated health
problems. Structured education programmes are suitable for use within the NHS and are already
recommended for individuals with T2DM, but have not been tested as a method of treatment for
PCOS which is a high risk condition for T2DM.
The investigators aim to initially develop a specific education programme for women with PCOS
using their expertise in their disease and defining their needs. The next step is to test
this programme on 160 women with PCOS who will be selected from the investigators database or
clinics. They will be divided randomly to two groups to receive either this programme or
routine care.
The investigators will give them an accelerometer (a very small portable device). This will
measure their physical activity and counts their daily steps. The investigators aim is to
increase their step count by at least 2000 steps per day after one year.
The investigators believe that the group given the structured education will show some
evidence of improvement in their glucose metabolism, and consequently decreased chance of
developing diabetes.
Overview of project plan:
Development of the structured education course: Year 1 (Phases 1&2)
Phase 1:
The SUCCESS intervention (structured education programme to improve cardiovascular risk in
women with PCOS) will be developed and piloted in line with the Medical Research Council's
framework for complex interventions. This will involve recruiting participants for focus
groups and interviews to allow the research group to develop a detailed understanding of what
the requirements of the structured education course are.
Inclusion criteria for patients in this phase is women with a clear diagnosis of PCOS based
on Rotterdam 2003 Criteria or National Institute of Health 1992 And 18< age <70 years
Participants will be recruited from a database of patients in our speciality clinic and also
primary care if needed and the interviews/ focus groups will be held in locations close to
the participant, or over the telephone.
Analysis of these sessions will provide invaluable data for the development of the structured
education course.
As part of this phase of the study we will perform a systematic review of the literature on
the previous lifestyle interventions in the PCOS.
We will also perform a demographic analysis of almost 2400 patients with diagnosis of PCOS in
University Hospitals of Leicester database. We already have the ethical approval for the
conducting routine database linkage studies including a linkage with the hospital admission
database in local Health Informatics Service. Demographic distribution of diagnosis,
complications of PCOS, cardiovascular outcomes, and reported comorbidities besides other
information such as deprivation score will inform us of the important issues need to be
considered in development of an education intervention for women with PCOS in phase 2 and 3.
Phase 2
Once the course has been designed, it will be piloted in one or two groups of women with PCOS
to get feedback on the content and delivery. These feedbacks will be incorporated in the
course and contents will be refreshed and refined.
For the above mentioned pilot sessions, patients will only attend a 3.5 hours education
session and no test or measurement will be done.
After each session their views on the content and delivery of the education will be sought.
We will continue to run these pilot sessions until we get no further new comments. Previous
experience with other similar interventions has shown that two pilot sessions are enough.
When the education programme is ready we can test its efficacy in a randomised controlled
trial.
Phase 3Íž Randomised controlled trial: Years 2 & 3
The primary hypothesis of the randomised controlled trial is:
"Structured education can increase physical activity measured as walking steps in women with
polycystic ovary syndrome."
Study design:
This is a randomised controlled community based trial. Participants will be randomised to
either the intervention or control group at the beginning. A controlled design for the
current study is essential given that it is unknown whether structured education is effective
at initiating a lifestyle change and whether it translates into improvements in important
markers of metabolic and vascular health. Therefore in order to inform health policy evidence
is needed from high quality randomized controlled trials carried out in a community setting.
Our study intervention will not interfere with the routine care of a woman diagnosed with
PCOS, whether the patient is recruited from speciality clinics or in primary care.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03142633 -
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
|
||
Completed |
NCT06158932 -
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Completed |
NCT04932070 -
Berberine and Polycystic Ovary Syndrome
|
N/A | |
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT03480022 -
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
|
Phase 3 | |
Active, not recruiting |
NCT03043924 -
Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT05246306 -
Aerobic Capacity and Physical Fitness Level of Adolescents With PCOS
|
||
Completed |
NCT05981742 -
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
|
Phase 2 | |
Completed |
NCT05702957 -
Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT05029492 -
Effect of Visceral Manipulation on PCOS
|
N/A | |
Not yet recruiting |
NCT02255578 -
Endobarrier Treatment in Women With PCOS
|
Phase 3 | |
Completed |
NCT02924025 -
Motivational Interviewing as an Intervention for PCOS
|
N/A | |
Completed |
NCT02098668 -
Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
|
N/A | |
Withdrawn |
NCT01638988 -
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
|
Phase 3 | |
Not yet recruiting |
NCT00883259 -
Metformin and Gestational Diabetes in High-risk Patients: a RCTs
|
Phase 4 | |
Recruiting |
NCT01431352 -
Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT00989781 -
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
|
N/A | |
Completed |
NCT00704912 -
Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women
|
Phase 2 |